R ecently, two high profile randomized controlled trials (RCTs) investigated the role of arthrodesis in determining the postoperative course for patients undergoing laminectomy for lumbar spondylolisthesis. 1, 2 The studies reached conflicting conclusions, with one study finding that arthrodesis improved patient disability and was associated with lower rates of surgical revision, while the other found no improved clinical outcomes, no reduction in surgical revision rates, and higher costs of care. Both studies found that arthrodesis was associated with longer postoperative hospital stays and more operative blood loss. These RCTs did not investigate any association between arthrodesis and postoperative opioid use.
Although RCTs excel in providing high-quality evidence by minimizing bias, these studies may be limited by cost, timeliness, small sample sizes, and applicability to realworld patient populations. 3 Observational studies using longitudinal databases can be helpful in assessing real-world outcomes that are difficult to capture in an RCT, or that the RCT was not designed to assess. 4 Lad et al 5 leveraged this advantage of observational databases studies by evaluating long-term complication and reoperation rates and health care utilization between laminectomy and laminectomy with lumbar arthrodesis for spondylolisthesis.
Although Lad et al provided important evidence for longterm outcomes and costs for patients with lumbar spondylolisthesis who receive surgical management, there was no assessment of pharmaceutical outcomes. Recent studies have utilized administrative claims data to assess narcotic use following surgery, a topic of great interest to patients, health care providers, and policy makers. 6 We analyzed a large, recent patient cohort focusing on pharmaceutical outcomes and geographic variation in narcotic utilization. The relationship between arthrodesis and postoperative narcotic use is particularly important, given the substantial geographic variation in arthrodesis and the substantial geographic variation in prescription opioid use established in previous studies. 7 
MATERIALS AND METHODS

Data Source
We performed a retrospective study of patients in the United States who received spinal surgical procedures for lumbar spondylolisthesis between 2007 and 2014. We used inpatient and outpatient longitudinal data from the Thomson Reuters MarketScan Commercial Claims and Encounters database, and the Medicare Supplemental and Coordination of Benefits database. These databases include information from 100 payers on inpatient, outpatient, and pharmacy services.
Cohort Definition
We developed our patient cohort by querying the MarketScan database for patients with Common Procedural Terminology (CPT) descriptors for lumbar laminectomy and arthrodesis and concurrent International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for spondylolisthesis. Our cohort primarily represents patients with degenerative spondylolisthesis, given patient characteristics such as older age at time of surgery, though we cannot definitively exclude patients with isthmic spondylolisthesis, as the ICD-9 diagnosis codes utilized capture both entities. This cohort definition has been previously established in the literature. 5 We excluded patients with ICD-9 or CPT codes for revision surgeries from the index cohort.
Outcomes
We investigated the relationship between arthrodesis and surgical complications, length of hospital stay, postoperative hospital readmission, revisions of the initial surgery, costs of care, and postoperative opioid use. Costs were computed as the sum of payments to the provider and hospital and calculated for both the index hospital stay and for 2 years following surgery. Index payments were excluded from consideration in 2-year cumulative payment calculations. To better characterize the use of arthrodesis in the United States, we also ran a sensitivity analysis to determine whether orthopedic surgeons or neurosurgeons were more likely to employ the procedure in the setting of lumbar spondylolisthesis. Detailed information about outcome definitions, including narcotic outcomes, is provided in the Appendix Methods, http://links.lww.com/BRS/B321.
Statistical Analysis
We used coarsened exact matching (CEM) to create an analytic sample balanced across procedure characteristics, patient demographics, and relevant comorbidities. CEM is similar to propensity score matching, in that it matches patients in the treatment group (those who underwent laminectomy with arthrodesis) with patients in the control group (those who underwent laminectomy without arthrodesis) who are most similar to each other across an array of covariates. However, unlike propensity score matching, CEM allows the level of covariate balance between the two groups to be specified before matching; it ensures a minimum degree of balance within the analytic sample. In addition to producing a more balanced sample, CEM reduces model dependence and estimation error compared with propensity score matching. 8 All covariates that were unbalanced (P < 0.05) in bivariate analyses between patients receiving arthrodesis and patients receiving laminectomy without arthrodesis were included in the matching procedure. CEM balanced the sample across the following variables: age; sex; single versus multiple laminectomy; preoperative diagnosis of congestive heart failure, myocardial infarction, osteoporosis, obesity, or diabetes; and geographic region of residence. Following CEM, we used logistic regression to analyze all binary outcomes (complications, readmissions, revisions), and linear regression to analyze continuous outcomes (days spent in hospital, costs of care, postoperative prescription of milligram morphine equivalents [MMEs] ). These regression models included year of surgery as a continuous variable in addition to the variables listed in Table 1 . Models of postoperative opioid prescription additionally adjusted for preoperative use of benzodiazepines, antipsychotics, and opioid use.
RESULTS
Cohort Overview
Our sample consists of 73,176 patients with lumbar spondylolisthesis who underwent laminectomy between 2007 and 2014. Of these patients, 67,262 (91.9%) received laminectomy with arthrodesis, and 62,613 (93.1%) of the patients receiving arthrodesis underwent an arthrodesis with instrumentation. 68,292 patients (93.3%) were successfully matched into the analytic sample; it was possible to balance the sample across the covariates listed in Table 1 while dropping relatively few patients because CEM achieves balance by re-weighting observations in the sample according to their covariates in addition to trimming observations that cannot be matched. Orthopedic surgeons were more likely than neurosurgeons to employ arthrodesis in conjunction with a laminectomy (OR ¼ 2.00, P < 0.01), although both orthopedic surgeons and neurosurgeons used arthrodesis in the vast majority of their procedures (94.8% and 90.2%, respectively).
Complications, Readmissions, and Revisions of Surgery
Patients who underwent laminectomy with arthrodesis were moderately more likely to experience a complication within 30 days of the procedure than patients who underwent laminectomy without arthrodesis (OR ¼ 1.15, P ¼ 0.04), but this risk was largely offset by the use of instrumentation in arthrodesis (OR ¼ 0.88, P < 0.01). The increased risk of complications in fusion procedures appears to occur primarily among patients undergoing noninstrumented arthrodesis (Table 2) . Neither arthrodesis nor instrumentation was associated with differences in 30-day readmission rates. However, patients who received arthrodesis were significantly less likely to have a record of any surgical revision in their follow-up period (OR ¼ 0.66, P < 0.01) ( Table 2 ).
Length of Stay and Cost
Patients who received arthrodesis spent approximately 1 day longer in the hospital following their procedure (P < 0.01) ( Table 3) . Instrumentation was not associated with increase in length of hospital stay. Both arthrodesis and instrumentation resulted in significantly more expensive procedures (arthrodesis was nearly $25,000 more expensive on average, P < 0.01, and instrumentation was over $10,000 more expensive on average, P < 0.01). However, costs of care aside from the costs of the index procedure were significantly lower at the 2-year mark for patients who underwent arthrodesis and for patients who underwent instrumentation. These lower costs of care did not fully offset the higher procedural costs of arthrodesis; at the 2-year mark, patients who underwent arthrodesis still had overall costs that were approximately $10,000 higher (Table 3) .
Postoperative Opioid Use
We find evidence that undergoing laminectomy with arthrodesis is associated with more opioid use in the first 2 months following surgery compared with laminectomy without arthrodesis (Table 4) . Patients who underwent arthrodesis received 288 (P < 0.01) more MMEs in the first month following surgery, and 172 (P < 0.01) more MMEs in the second month after their surgery compared with patients who underwent laminectomy alone. However, this difference does not appear to persist beyond 2 months; arthrodesis patients did not receive significantly more opioids than laminectomy-only patients at any point between postoperative month 3 and postoperative month 24 (Figure 1 ). Additionally, patients who had received arthrodesis were not more likely to have stopped using opioids by 6 months after their procedure, nor were they more likely to meet the criteria for chronic opioid use in their postoperative period (Table 4) .
Geographic Variation in Opioid Use
We found substantial variation in opioid use between states ( Figure 2) . We limited our analysis of geographic variation to states with drug information from at least 100 patients in our dataset (43 states, excluding Alaska, Hawaii, North Dakota, Rhode Island, South Dakota, Vermont, Wyoming, and the District of Columbia). Opioid use before receiving laminectomy was common among all states in our dataset; at least 50% of patients receiving laminectomy were using opioids before their procedure in all states but two (New Mexico, 24%, and Nebraska, 47%). The prevalence of preoperative opioid use was highest in Mississippi (73%). Preoperative use of benzodiazepines was also lowest in New Mexico, where 15% of patients used benzodiazepines before undergoing laminectomy, and highest in Connecticut, where 36% of patients had filled benzodiazepine prescriptions within the 6 months preceding their operation (Appendix Table 1 This substantial variation in postoperative opioid use between states persists even after accounting for the patient and procedure characteristics that are associated with opioid use in our analyses. We conducted a sensitivity analysis that estimated the relationship between arthrodesis and postoperative opioid use while including a separate binary variable for every state, in addition to the covariates included in our primary model; a joint test of significance for all of the geographic binary variables in this model was strongly significant (P < 0.01), indicating that geographic variation in postoperative opioid use exists even after accounting for patient characteristics and characteristics of the laminectomy procedure that are likely to be associated with opioid use (e.g., employment of arthrodesis).
DISCUSSION
This retrospective observational database study of 73,176 surgical patients with lumbar spondylolisthesis finds evidence that the incorporation of arthrodesis in patients undergoing laminectomy impacts an array of clinically significant outcomes, including costs of care, surgical revisions, complications in the postoperative period, and postoperative use of opioids. We find that arthrodesis is associated with reduced likelihood of surgical revision, but is also associated with increased total costs, slightly longer hospital stays, increased likelihood of postoperative complications within 30 days of surgery (a finding largely driven by patients receiving noninstrumented arthrodesis), and increased use of opioids in the first 2 months following surgery. We also find tremendous variation in the degree of postoperative opioid use in different states, even after Table 4 .
accounting for differences between patient populations between states. We find evidence that patients undergoing laminectomy with arthrodesis fill significantly more opioid prescriptions in the first and second postoperative months compared with patients undergoing laminectomy alone. However, we do not find evidence that this higher use of opioids in the immediate postsurgical period is associated with longerterm opioid use. Patients undergoing arthrodesis are no more likely to convert to chronic use of opioids within 2 years of surgery, nor are they more likely to be consuming higher doses of opioids in postoperative months 3 to 24. Arthrodesis appears unlikely to be a significant contributor to chronic opioid use in these patients. Conversely, addition of arthrodesis does not increase the likelihood that patients will be able to cease narcotic use in the postoperative period assessed in this analysis. Use of opioids between the fusion and nonfusion patient cohorts appear similar after the initial 2 months postoperatively.
Although arthrodesis is a significant predictor of opioid use in the immediate postoperative period, a patient's state of residence is an even stronger predictor of opioid use. The state-by-state variation in postoperative opioid use observed is substantially greater than the average difference in opioid use between arthrodesis and laminectomy-alone patients. We find that similar patients undergoing similar procedures (e.g., patients with similar comorbidities who both undergo single-level laminectomy with or without arthrodesis) are likely to receive substantially different amounts of opioids postoperatively depending upon what state they live in. Our previous analysis of this dataset found that state of residence was an important predictor of whether patients received arthrodesis in conjunction with their laminectomy; in thisanalysis we find that arthrodesis is associated with increased opioid use, but that state of residence is a vital predictor of opioid use even after accounting for whether a patient receive arthrodesis. Patients with lumbar spondylolisthesis face dramatically different operative and postoperative courses depending upon their geography; similar patients in different states face different likelihoods of receiving arthrodesis when they undergo laminectomy for lumbar spondylolisthesis and also experience very different approaches for management of their postoperative pain. Further research should investigate whether this state variation in opioid use is similar in other surgical patient populations, and whether state-specific prescription modalities are associated with broader trends in opioid abuse.
Our results indicate that patient characteristics explain only some of the variation in surgical and postsurgical management of lumbar spondylolisthesis. Patient outcomes are associated with patient characteristics, but are also associated with the type of surgical procedure they underwent. Postoperative pain management is associated with patient characteristics and with type of surgical procedure, but is also strongly associated with geography. These findings are in line with the results of an earlier analysis conducted by this team, which noted substantial geographic variation in the employment of arthrodesis in patients undergoing laminectomy for lumbar spondylolisthesis. We also note that employment of arthrodesis in laminectomy was associated with surgical specialty; orthopedic surgeons were approximately twice as likely to use arthrodesis in laminectomies compared with neurosurgeons (OR ¼ 2.00, P < 0.01).
These results demonstrate substantial heterogeneity in the management of a well-defined population of spine surgery patients in the United States. This heterogeneity exists even within the relatively homogeneous population used in this analysis, a population drawn from the MarketScan database of relatively younger, privately insured patients. This analytic approach necessarily eliminates variation based upon advanced patient age, through lack of Medicare beneficiaries. The analysis also fails to adequately capture variation in patient care based upon socioeconomic status, through lack of inclusion of Medicaid and un-insured patients. While lack of these elements are limitations of our analytic approach, they might be expected to generate a more homogeneous patient population, with less variation in treatment protocols. This analysis failed to reveal homogeneity in treatment approaches in this population.
This study was subject to several additional limitations. Our outcomes in this study do not include clinical findings which may be relevant to patient care but which are not included in an administrative insurance database; it is likely that there are advantages (or disadvantages) to arthrodesis, which are not reflected in complication rates and other relatively crude measures of procedure efficacy. Our clinical outcomes, specifically reoperation rates, are coarse. Similarly, our pharmacological data are a relatively crude measure of opioid use, because prescription of opioids may only approximate their use (some patients may not use the drugs they are prescribed, while others may find additional sources of opioids beyond their own prescriptions). We rely upon the accuracy of procedural and facility coding of the individual procedures and of patient comorbidities in this analysis; both may be subject to bias. The underreporting of postoperative complications in administrative datasets has been well described, although by using longitudinal data we may obviate this concern. 4 
CONCLUSION
Narcotic use postoperatively varies more based upon geography than by choice of operative procedure in surgical treatment of lumbar spondylolisthesis. Narcotic use between fusion and nonfusion patient cohorts are similar. The use of arthrodesis in surgical management of lumbar spondylolisthesis varies markedly in the United States in ways that cannot be fully explained by variation in patient characteristics. Fully understanding the risks and benefits of arthrodesis is important for establishing best practices and for characterizing geographic variation in surgical outcomes, costs of lumbar spondylolisthesis, and postoperative opioid use.
